Monte-Carlo, Monaco — 27–29 March 2025 — Genèse Labs took part in the 23rd Aesthetic & Anti-Aging Medicine World Congress (AMWC) at the Grimaldi Forum, presenting its expanded portfolio to practitioners and distribution partners from around the world.

• Participation in AMWC Monaco, the leading international congress for aesthetic and anti-ageing medicine

• More than 15,000 delegates and industry professionals from around 140 countries

• First congress presentation of the complete Proluma™ line, including the newly launched PLLA

• Strengthened presence in Europe as a French-headquartered company

Held under the patronage of H.S.H. Prince Albert II of Monaco for more than two decades, AMWC is the leading congress at which dermatologists, plastic surgeons and aesthetic physicians share the latest clinical evidence and technology. Combining scientific sessions with a major exhibition, it is also where new products first face the scrutiny of the international medical community.

For Paris-headquartered Genèse Labs, AMWC Monaco is a home stage. Presenting products designed and certified within the European regulatory framework directly to European practitioners is the most direct demonstration of the brand’s scientific and regulatory credibility.

At the centre of the booth was the Proluma™ line of PDLLA 200 mg and the newly launched PLLA 365 mg. The ability to select between the two by treatment depth and patient profile drew strong practitioner interest. RG60® HA Body Filler, Citrus Bottle™ and the Exoluma™ series were also presented.

AMWC Monaco opened Genèse Labs’ 2025 international congress programme — the first stop in a year that would go on to include the Middle East, Southeast Asia, Russia, Latin America and Indonesia.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.